Global Immunotherapeutic Drugs Market Research Report 2023

Report ID: 1875921 | Published Date: Oct 2024 | No. of Page: 87 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibody
        1.2.3 Vaccines
        1.2.4 Checkpoint Inhibitor
        1.2.5 Interferon
    1.3 Market by Application
        1.3.1 Global Immunotherapeutic Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Immunotherapeutic Drugs Market Perspective (2017-2028)
    2.2 Immunotherapeutic Drugs Growth Trends by Region
        2.2.1 Immunotherapeutic Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Immunotherapeutic Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Immunotherapeutic Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Immunotherapeutic Drugs Market Dynamics
        2.3.1 Immunotherapeutic Drugs Industry Trends
        2.3.2 Immunotherapeutic Drugs Market Drivers
        2.3.3 Immunotherapeutic Drugs Market Challenges
        2.3.4 Immunotherapeutic Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Immunotherapeutic Drugs Players by Revenue
        3.1.1 Global Top Immunotherapeutic Drugs Players by Revenue (2017-2022)
        3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Immunotherapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Immunotherapeutic Drugs Revenue
    3.4 Global Immunotherapeutic Drugs Market Concentration Ratio
        3.4.1 Global Immunotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Immunotherapeutic Drugs Revenue in 2021
    3.5 Immunotherapeutic Drugs Key Players Head office and Area Served
    3.6 Key Players Immunotherapeutic Drugs Product Solution and Service
    3.7 Date of Enter into Immunotherapeutic Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Immunotherapeutic Drugs Breakdown Data by Type
    4.1 Global Immunotherapeutic Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Immunotherapeutic Drugs Forecasted Market Size by Type (2023-2028)
5 Immunotherapeutic Drugs Breakdown Data by Application
    5.1 Global Immunotherapeutic Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Immunotherapeutic Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Immunotherapeutic Drugs Market Size (2017-2028)
    6.2 North America Immunotherapeutic Drugs Market Size by Country (2017-2022)
    6.3 North America Immunotherapeutic Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Immunotherapeutic Drugs Market Size (2017-2028)
    7.2 Europe Immunotherapeutic Drugs Market Size by Country (2017-2022)
    7.3 Europe Immunotherapeutic Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Immunotherapeutic Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Immunotherapeutic Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Immunotherapeutic Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Immunotherapeutic Drugs Market Size (2017-2028)
    9.2 Latin America Immunotherapeutic Drugs Market Size by Country (2017-2022)
    9.3 Latin America Immunotherapeutic Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Immunotherapeutic Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Detail
        11.1.2 Roche Business Overview
        11.1.3 Roche Immunotherapeutic Drugs Introduction
        11.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2017-2022)
        11.1.5 Roche Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck Immunotherapeutic Drugs Introduction
        11.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2017-2022)
        11.2.5 Merck Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Immunotherapeutic Drugs Introduction
        11.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Detail
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Immunotherapeutic Drugs Introduction
        11.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Development
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Detail
        11.5.2 GlaxoSmithKline Business Overview
        11.5.3 GlaxoSmithKline Immunotherapeutic Drugs Introduction
        11.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2017-2022)
        11.5.5 GlaxoSmithKline Recent Development
    11.6 AbbVie
        11.6.1 AbbVie Company Detail
        11.6.2 AbbVie Business Overview
        11.6.3 AbbVie Immunotherapeutic Drugs Introduction
        11.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2017-2022)
        11.6.5 AbbVie Recent Development
    11.7 ELI Lilly
        11.7.1 ELI Lilly Company Detail
        11.7.2 ELI Lilly Business Overview
        11.7.3 ELI Lilly Immunotherapeutic Drugs Introduction
        11.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2017-2022)
        11.7.5 ELI Lilly Recent Development
    11.8 Amgen
        11.8.1 Amgen Company Detail
        11.8.2 Amgen Business Overview
        11.8.3 Amgen Immunotherapeutic Drugs Introduction
        11.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2017-2022)
        11.8.5 Amgen Recent Development
    11.9 AstraZeneca
        11.9.1 AstraZeneca Company Detail
        11.9.2 AstraZeneca Business Overview
        11.9.3 AstraZeneca Immunotherapeutic Drugs Introduction
        11.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2017-2022)
        11.9.5 AstraZeneca Recent Development
    11.10 Bristol-Mysers Squibb
        11.10.1 Bristol-Mysers Squibb Company Detail
        11.10.2 Bristol-Mysers Squibb Business Overview
        11.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Introduction
        11.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2017-2022)
        11.10.5 Bristol-Mysers Squibb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Immunotherapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Monoclonal Antibody
    Table 3. Key Players of Vaccines
    Table 4. Key Players of Checkpoint Inhibitor
    Table 5. Key Players of Interferon
    Table 6. Global Immunotherapeutic Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Immunotherapeutic Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Immunotherapeutic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Immunotherapeutic Drugs Market Share by Region (2017-2022)
    Table 10. Global Immunotherapeutic Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Immunotherapeutic Drugs Market Share by Region (2023-2028)
    Table 12. Immunotherapeutic Drugs Market Trends
    Table 13. Immunotherapeutic Drugs Market Drivers
    Table 14. Immunotherapeutic Drugs Market Challenges
    Table 15. Immunotherapeutic Drugs Market Restraints
    Table 16. Global Immunotherapeutic Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Immunotherapeutic Drugs Market Share by Players (2017-2022)
    Table 18. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapeutic Drugs as of 2021)
    Table 19. Ranking of Global Top Immunotherapeutic Drugs Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Immunotherapeutic Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Immunotherapeutic Drugs Product Solution and Service
    Table 23. Date of Enter into Immunotherapeutic Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Immunotherapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Immunotherapeutic Drugs Revenue Market Share by Type (2017-2022)
    Table 27. Global Immunotherapeutic Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Immunotherapeutic Drugs Revenue Market Share by Type (2023-2028)
    Table 29. Global Immunotherapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Immunotherapeutic Drugs Revenue Market Share by Application (2017-2022)
    Table 31. Global Immunotherapeutic Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Immunotherapeutic Drugs Revenue Market Share by Application (2023-2028)
    Table 33. North America Immunotherapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Immunotherapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Immunotherapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Immunotherapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Immunotherapeutic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Immunotherapeutic Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Immunotherapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Immunotherapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Roche Company Detail
    Table 44. Roche Business Overview
    Table 45. Roche Immunotherapeutic Drugs Product
    Table 46. Roche Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 47. Roche Recent Development
    Table 48. Merck Company Detail
    Table 49. Merck Business Overview
    Table 50. Merck Immunotherapeutic Drugs Product
    Table 51. Merck Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 52. Merck Recent Development
    Table 53. Novartis Company Detail
    Table 54. Novartis Business Overview
    Table 55. Novartis Immunotherapeutic Drugs Product
    Table 56. Novartis Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 57. Novartis Recent Development
    Table 58. Johnson & Johnson Company Detail
    Table 59. Johnson & Johnson Business Overview
    Table 60. Johnson & Johnson Immunotherapeutic Drugs Product
    Table 61. Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 62. Johnson & Johnson Recent Development
    Table 63. GlaxoSmithKline Company Detail
    Table 64. GlaxoSmithKline Business Overview
    Table 65. GlaxoSmithKline Immunotherapeutic Drugs Product
    Table 66. GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 67. GlaxoSmithKline Recent Development
    Table 68. AbbVie Company Detail
    Table 69. AbbVie Business Overview
    Table 70. AbbVie Immunotherapeutic Drugs Product
    Table 71. AbbVie Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 72. AbbVie Recent Development
    Table 73. ELI Lilly Company Detail
    Table 74. ELI Lilly Business Overview
    Table 75. ELI Lilly Immunotherapeutic Drugs Product
    Table 76. ELI Lilly Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 77. ELI Lilly Recent Development
    Table 78. Amgen Company Detail
    Table 79. Amgen Business Overview
    Table 80. Amgen Immunotherapeutic Drugs Product
    Table 81. Amgen Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 82. Amgen Recent Development
    Table 83. AstraZeneca Company Detail
    Table 84. AstraZeneca Business Overview
    Table 85. AstraZeneca Immunotherapeutic Drugs Product
    Table 86. AstraZeneca Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 87. AstraZeneca Recent Development
    Table 88. Bristol-Mysers Squibb Company Detail
    Table 89. Bristol-Mysers Squibb Business Overview
    Table 90. Bristol-Mysers Squibb Immunotherapeutic Drugs Product
    Table 91. Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 92. Bristol-Mysers Squibb Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Immunotherapeutic Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Monoclonal Antibody Features
    Figure 3. Vaccines Features
    Figure 4. Checkpoint Inhibitor Features
    Figure 5. Interferon Features
    Figure 6. Global Immunotherapeutic Drugs Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Other Case Studies
    Figure 10. Immunotherapeutic Drugs Report Years Considered
    Figure 11. Global Immunotherapeutic Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Immunotherapeutic Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Immunotherapeutic Drugs Market Share by Region: 2021 VS 2028
    Figure 14. Global Immunotherapeutic Drugs Market Share by Players in 2021
    Figure 15. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapeutic Drugs as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Immunotherapeutic Drugs Revenue in 2021
    Figure 17. North America Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Immunotherapeutic Drugs Market Share by Country (2017-2028)
    Figure 19. United States Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Immunotherapeutic Drugs Market Share by Country (2017-2028)
    Figure 23. Germany Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Immunotherapeutic Drugs Market Share by Region (2017-2028)
    Figure 31. China Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Immunotherapeutic Drugs Market Share by Country (2017-2028)
    Figure 39. Mexico Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Immunotherapeutic Drugs Market Share by Country (2017-2028)
    Figure 43. Turkey Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Immunotherapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Roche Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 46. Merck Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 47. Novartis Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 48. Johnson & Johnson Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 49. GlaxoSmithKline Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 50. AbbVie Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 51. ELI Lilly Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 52. Amgen Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 53. AstraZeneca Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 54. Bristol-Mysers Squibb Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb
Frequently Asked Questions
Immunotherapeutic Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Immunotherapeutic Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Immunotherapeutic Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pediatric wheelchair

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Small Molecule API

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More